VASCULAR BIOGENICS LTD (VBLT)

IL0011327454 - Common Stock

0.156  -0.02 (-8.77%)

After market: 0.168 +0.01 (+7.69%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-6-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
481.00K658.00K768.00K920.00K560.00K
Cost Of Goods
17.00K104.00K365.00K390.00K220.00K
Gross Profit
464.00K554.00K403.00K530.00K340.00K
Operating Expenses
16.76M33.41M30.40M25.02M20.42M
Research and Development
N/A367.00K774.00K830.00K1.24M
Selling, General, and Administrative Expenses
10.78M11.75M7.70M5.36M5.71M
Operating Income
-16.30M-32.85M-30.00M-24.48M-20.08M
Interest Income/Expense
270.00K549.00K76.00K260.00K690.00K
Other Income/Expense
N/AN/AN/AN/AN/A
Income Before Taxes
-15.96M-32.30M-29.92M-24.23M-19.40M
Net Income
-15.96M-32.30M-29.92M-24.23M-19.40M
EBITDA
N/A-31.80M-28.74M-23.29M-18.86M
 
Per Share Data
EPS Diluted Total Ops
-0.21-0.42-0.45-0.55-0.54
Non GAAP EPS
N/AN/A-0.45-0.56-0.55
 
Statistics
Gross Profit Margin
96.47%84.19%52.47%57.61%60.71%
Profit Margin
-3317.05%-4909.42%-3895.83%-2633.70%-3464.29%
Operating Profit Margin
-3388.57%-4992.86%-3905.73%-2660.87%-3585.71%

All data in USD

Charts